Home › Funds › Intesa Sanpaolo S.p.A. › ELV
Intesa Sanpaolo S.p.A. position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Intesa Sanpaolo S.p.A. reported holding 77,155 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$30.0M, representing 1.03% of its reported portfolio and ranking #24 among its reported holdings. Intesa Sanpaolo S.p.A. has disclosed ELV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Intesa Sanpaolo S.p.A.'s ELV position evolved
Intesa Sanpaolo S.p.A. first disclosed a stake in ELV in Q4 2025 at 41,286 shares (US$14.4M). The position peaked in Q3 2026 at 77,155 shares, worth US$30.0M. Across 4 filings, Intesa Sanpaolo S.p.A. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 77,155 shares valued at US$30.0M — an increase of 30,151 shares quarter over quarter.. Notable position changes include a 64% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 41.29K | $14.40M | New |
| Q1 2026 | 47.56K | $13.92M | Add |
| Q2 2026 | 47.00K | $18.18M | Reduce |
| Q3 2026 | 77.16K | $30.00M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.31B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.52M sh · $3.31B · Q3 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Intesa Sanpaolo S.p.A.
FAQ
How long has Intesa Sanpaolo S.p.A. held ELV?
Intesa Sanpaolo S.p.A. has disclosed ELV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Intesa Sanpaolo S.p.A.'s current position in ELV?
As of Q3 2026, Intesa Sanpaolo S.p.A. holds 77.16K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $30.00M, representing 1.03% of its reported portfolio and ranking #24.
Has Intesa Sanpaolo S.p.A. been buying or selling ELV?
In the latest 13F filing (Q3 2026), Intesa Sanpaolo S.p.A. increased its position in ELV. The position peaked in Q3 2026 at 77.16K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.